Something Is Happening In Your Body Right Now. You Cannot Feel It Yet.

Why age-related muscle decline may become one of the most important longevity investment themes of the next decade, and how I think about Dual ROI before the market catches up.

The 2026 Epigenetic Reprogramming Watchlist: 5 Companies Working To Reset Cellular Age

Big Pharma Has $236 Billion Disappearing by 2030. Let's Look At What They Might Be Looking For.

I Learned This From Selling Part Of My Company. Build What The Buyer Already Needs. Then Overlap It With What May Keep Us Alive.

Start With The End in Mind: How Big Pharma Actually Decides Which Biotech Companies to Acquire

I've watched dozens of companies in my 411-company longevity universe get acquired. A pattern kept repeating. Then I remembered selling part of CuraDebt - and realized biotech M&A works exactly the same way.

The Muscle Problem Nobody Is Talking About

Sarcopenia, The Science Of Saving Your Strength, And The Companies I Am Watching Right Now

The 2026 Big Pharma Shopping List

Where I See The Smart Money Moving - And Why

Retroactive Analysis: Applying The 25-Gate Framework To 10 Years Of Longevity Biotech (Hypothetical)

~4.2x hypothetical return. ~$8.0 million in paper gains. Two losses. 411 biotech companies reviewed. 10 years.

I Was Swimming In Brown Ocean Water In Santa Marta When It Hit Me.

The longevity intervention that costs nothing, takes five minutes, and has harder data behind it than half the supplements in my cabinet (or companies I'm evaluating).

I Watched Prometheus Last Night. The Cryopods Almost Aren't Fiction Anymore.

Why cryopreservation forced me to add a whole new classification to the EverLife Capital framework, and what that means for a healthy 45-year-old targeting 120+.

Longevity Escape Velocity: The Timeline Nobody Agrees On, What Each Expert Is Actually Doing About It, And Why It Matters To You

I want to have this conversation with you the way I'd have it over coffee. No hype. No "scientists hate this one trick." Just an honest look at what the smartest people working on aging actually believe, where they disagree, what they're personally doing to bridge the gap, and what it means for people like you and me who are trying to figure out how to plan the next 30, 50, or maybe 80 years of our lives.

What Is Longevity Biotech And Why It May Be The Most Underinvested Sector In History

A complete map: the 12 hallmarks of aging, the frontier technologies going beyond conventional medicine, and a framework for evaluating longevity biotechs.

I Spent 24 Years In Finance. Now I’m Focusing On Longevity Biotech.

How turning 51 changed how I think about priorities in life, and what really matters.

Longevity Biotech For The 45+ Investor: Seeking Asymmetric Upside And Lifespan Impact

Let me tell you how I got here.

Full Disclosure And Terms Of Research